Role of prostaglandins in the stimulation of the hypothalamic-pituitary-adrenal axis by adrenergic and neurohormone systems

Journal of Physiology and Pharmacology

Volumn 47, Issue 4, 1996, Pages 559-575

  Bugajski, J ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

adrenergic agonists; adrenergic receptors; corticotropin releasing hormone; hypothalamic pituitary adrenal axis; indomethacin; neurohormone systems adaptation interleukins; prostaglandins; social stress; vasopressin

Indexed keywords

ADRENALIN; ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CORTICOSTERONE; CORTICOTROPIN RELEASING FACTOR; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; ISOPRENALINE; NORADRENALIN; PHENYLEPHRINE; PROSTAGLANDIN DERIVATIVE; VASOPRESSIN;

ANIMAL EXPERIMENT; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; RAT; REVIEW; STRESS;

ADRENERGIC AGONISTS; ANIMALS; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INDOMETHACIN; INTERLEUKIN-1; PITUITARY-ADRENAL SYSTEM; PROSTAGLANDINS; STRESS; VASOPRESSINS;

EID: 0030447477     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (78)

1. Katsuki H, Okuda S. Arachidonic acid as a neurotoxic and neurotrophic substance. Prog Neurobiol 1995; 46: 607-636.
2. Piomelli D, Arachidonic acid. In: Psychopharmacology: The fourth generation of progress. FE Bloom and DJ Kupfer (ed). New York, Raven Press Ltd, 1995, pp. 595-607.
3. Wolfe LS, Horrocks LA, Eicosanoids. In: Basic neurochemistry: Molecular, Cellular and Medical Aspects. GJ Siegel et al (ed.) New York, Raven Press Ltd, 1994, pp: 475-490.
4. Schaad NC, Magistretti PJ, Schorderet M Prostanoids and their role in cell-cell intractions in the central nervous system. Neurochem Int 1991; 18: 303-332.
5. Cooper CL, Malik KU. Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked to activation of alpha-1 adrenergic receptors in the isolated rat kidney. J Pharmacol Exp Ther 1985; 233: 24-31.
6. Cooper CL, Malik KU. Mechanism of action of vasopressin on prostaglandin synthesis and vascular function in the isolated rat kidney: effect of calcium antagonists and calmodulin inhibitors. J Pharmacol Exp Ther 1984; 229: 139-147.
7. Shaffer JE, Malik KU. Enhancement of prostaglandin output during activation of beta-1 adrenoceptors in the isolated rabbit heart. J Pharmacol Exp Ther 1982; 223: 729-735.
8. Van Praag D, Minkin E, Farber SJ. Inhibition of eicosanoid formation by prazosin in the rabbit renal cortex. Prostagland Leuk Med 1986; 24: 227-240.
9. Nebigil C, Malik KU. Prostaglandin synthesis elicited by adrenergic stimuli in rabbit aorta is mediated via alpha-1 and alpha-2 adrenergic receptors. J Pharmacol Exp Therapeut 1990; 254: 633-640.
10. 2 and arachidonic acid release in signal transduction. Biochem Soc Transactions 1990; 18: 503-507.
11. Thompson ME, Hedge GA. Corticosterone secretion after inhibition of prostaglandin synthesis by indomethacin. Am J Physiol 1981; 240: E131-E135.
12. 2 inhibition of corticotropin releasing factor-mediated ACTH release. Brain Res 1987; 411: 102-107.
13. 2 of the release of vasopressin and beta-endorphin from rat pituitary neurointermediate lobe or medial basal hypothalamus in vitro. J Endocrinol 1985; 106: 189-195.
14. Thoren M, Stenfors C, Aperia B, Mathe AA. Hypothalamic-pituitary-adrenal axis interaction with prostaglandins. Prog Neuro-Psychopharmacol Biol Psychiat 1990; 14: 319-328.
15. Hindawi RK, Al-Dujaili EAS, Padfield PL. The role of prostaglandins in aldosterone and corticosterone secretion by isolated perfused rat zona glomerulosa cells. Prostagland Leuk Med 1985; 20: 121-128.
16. 2. J Physiol 1991; 443: 431-439.
17. Bugajski J, Ga̧dek-Michalska A, Borycz J, Głód R, Bugajski JA. Effect of indomethacin on the pituitary-adrenocortical response to adrenergic stimulation. Life Sci 1996; 59: 1157-1164.
18. Bugajski J, Ga̧dek-Michalska A, Borycz J, Głód R, Ołowska A. The role of prostaglandins and the hypothalamic and hippocampal histamine in the clonidine-induced pituitary-adrenocortical response. J Physiol Pharmacol 1996; 47: 487-495.
19. Goldstein GW, Betz AL. The blood-brain barrier. Sci Amer 1986; 254: 74-83.
20. Katsuura G, Arimura A, Koves K, Gottschall PE. Involvement of organum vasculosum of lamina terminalis and preoptic area in interleukin 1β-induced ACTH release. Am J Physiol 1990; 258: E163-E171.
21. Ermisch A, Ruhle H-J. Peptide-blood-brain barrier interactions: kinetics and dynamics. J Control Release 1992; 21: 93-104.
22. Al-Damluji S, Thomas R, White A, Besser M. Vasopressin mediates alpha-1 adrenergic stimulation of adrenocorticotropin secretion. Endocrinology 1990; 126: 1989-1995.
23. Brooks DP, Share L, Crofton JT. Central adrenergic control of vasopressin release. Neuroendocrinology 1986; 42: 416-420.
24. Bugajski J, Ga̧dek-Michalska A, Otowska A, Borycz J, Głód R, Bugajski AJ. Adrenergic regulation of the hypothalamic-pituitary-adrenal axis under basal and social stress conditions. J Physiol Pharmacol 1995; 46: 297-312.
25. Brooks DP, Share L, Crofton JT. Role of brain prostaglandins in the control of vasopressin secretion in the conscious rat. Endocrinology 1986, 118: 1716-1722.
26. 2+ and by phosphorylation via protein kinase C. J Lipid Mediators Cell Signalling 1994; 10: 23-24.
27. Joanny P, Steinberg J, Zamora AJ, Conte-Devolx B, Millet Y, Olivier C. Corticotropin-releasing factor release from in vitro superfused and incubated rat hypothalamus. Effect of potassium, norepinephrine, and dopamine. Peptides 1989; 10: 903-911.
28. Tilders FJH, Berhenbosch F, Vermes I. Circulating epinephrine stimulates ACTH secretion in rats via beta-adrenoceptors located in the brain. Neuroendocrine Perspectives E.E. Muller EE, Mac Leod RM. (EDs(. 1986; 5: 329-333. Elselvier Sciences Publishers B. V. (Biomedical Division) Amsterdam.
29. Watanobe T, Morimoto A, Sakata Y, Murakami N. ACTH response induced by interleukin-1 is mediated by CRF secretion stimulated by hypothalamic PGE. Experimentia 1990; 46: 481-484.
30. Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76-122.
31. Rivier C. Effect of peripheral and central cytokines on the hypothalamic-pituitary-adrenal axis of the rat. Ann NY Acad Sci 1993; 697: 97-105
32. Rivier C, Vale W. Stimulatory effects of interleukin-1 on adrenocorticotropin secretion in the rat: Is it modulated by prostaglandins? Endocrinology 1991; 129: 384-388.
33. 2, corticotropin releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfussion. Neuroendocrinology 1984, 60: 8-15.
34. Lyson K, McCann SM. Involvement of arachidonic acid cascade pathways in interleukin-6-stimulated corticotropin-releasing factor release in vitro. Neuroendocrinology 1992; 55: 708-713.
35. Katsuura G, Gottschall PE, Dahl RR, Arimura A. Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats. Possible involvement of prostaglandins. Endocrinology 1988; 122: 1773-1779.
36. 2 levels in several brain areas as determined by microdialysis. Am J Physiol 1992; 262: E246-251.
37. Rivest S, Torres G, Rivier C. Differential effects of central and peripheral injection of interleukin-1β on brain c-fos expression and neuroendocrine functions. Brain Res 1992; 587: 13-23.
38. Watanobe H, Sasaki S, Takebe K. Evidence that intravenous administration of interleukin-1 stimulates corticotropin releasing hormone secretion in the median eminence of freely moving rats: estimation by push-pull perfusion. Neurosci Lett 1991; 133: 7-10.
39. Zhou D, Kusnecov AW, Shunn MR, DePaoli M, Rabin BS. Exposure to physical and psychological Stressors elevates plasma interleukin 6: Relatioship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology 1993; 133: 2523-2530.
40. Smith EM. Hormonal activities of cytokines. In: Chem Immunol. K Ishizaka, PJ Lachmann, R Lerner, BH Waksman (ed). Basel, Karger 1992; 52: 154-169.
41. Ohmichi M, Hirota K, Koike K et al. Binding sites for interleukin-6 in the anterior pituitary gland. Neuroendocrinology 1992; 55: 199-203.
42. 2 from rat hypothalamic explants in vitro. Neuroendocrinology 1992; 56: 61-68.
43. Ohgo S, Nakatsuru K, Ishikawa E, Matsukura S. Interleukin-1 (IL-1) stimulates the release of corticotropin-releasing factor (CRF) from superfused rat hypothalamo-neurohypophyseal complexes (HNC) independently of the histaminergic mechanism. Brain Res 1991; 558: 217-223.
44. Spangelo BL, Wright RM. Arachidonic acid stimulates interleukin 6 release from rat anterior pituitary cells in vitro: comparison with peritoneal macrophages. Prog Neuro Endocrin Immunol 1992; 5: 235-244.
45. Terao A, Oikawa M, Saito M. Cytokine-induced change in hypothalamic norepinephrine turnover: involvement of corticotropin-releasing hormone and prostalandins: Brain Res 1993; 622: 257-261.
46. 2 in interleukin-1-induced activation of norepinephrine turnover in the brain and peripheral organs of rats. J Neurochem 1995; 65: 2742-2747.
47. Barbanel G, Gaillet S, Mekaouche M et al. Complex catecholaminergic modulation of the stimulatory effect of interleukin-1β on the corticotropic axis. Brain Res 1993; 626: 31-36.
48. Shintani F, Kanba S, Nakaki T et al.Interleukin-1β augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus. J Neurosci 1993; 13: 3574-3581.
49. Whitnall MH, Perlstein RS, Mougey EH, Neta R. Effects of interleukin-1 on the stress-responsive and-nonresponsive subtypes of corticotropin-releasing-hormone neurosecretory axons. Endocrinology 1992; 131: 37-44.
50. Weidenfeld J, Crumeyrolle-Arias M, Haour F. Effect of bacterial endotoxin and interleukin-1 on prostaglandin biosynthesis by the hippocampus of mouse brain: Role of interleukin-1 receptors and glucocorticoids. Neuroendocrinology 1995; 62: 39-46.
51. 2 and bacterial lipopolysaccharide stimulate bioactive interleukin-1 release from rat hypothalamic explants. Neuroendocrinology 1993; 57: 257-261.
52. Morimoto A, Mukarami N, Nakamori T, Sakata Y, Watanobe T. Possible involvement of prostaglandin E in development of ACTH response in rats induced by human recombinant interleukin-1. J Physiol 1989; 411: 245-256.
53. 2, corticotropin-releasing factor, and arginine vasopressin in several hypothalamic areas of freely moving rats: estimation by push-pull perfusion. Neuroendocrinology 1994; 60: 8-15.
54. Cambronero JC, Rivas FJ, Borrell J, Guaza C. Role of arachidonic acid metabolism on corticotropin- releasing factor (CRF)-release induced by interleukin-1 from superfused rat hypothalami. J Neuroimmunol 1992; 39: 57-66.
55. 2α in the brain in interleukin 1β-induced adrenocorticotropin secretion in the rat. Cytokine 1995; 7: 710-712.
56. Andreis PG, Neri G, Belloni AS, Mazzocchi G, Kasprzak A, Nussdorfer GG. Interleukin-1β enhances corticosterone secretion by acting directly on the rat adrenal gland Endocrinology 1991; 129: 53-57.
57. Judd AM, MacLeod RM. Adrenocorticotropin increases interleukin-6 release from rat adrenal zona glomerulosa cells. Endocrinology 1992; 130: 1245-1254.
58. Gwosdow AR, O'Connell NA, Spencer JA et al. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am J Physiol 1992; 263: E461-E466.
59. Haour F, Marquette C, Ban E et al. Receptors for interleukin-1 in the central nervous and neuroendocrine systems. Role in infection and stress. Ann Endocrinol 1995; 56: 173-179.
60. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993; 40: 573-629.
61. Levin N, Blum M, Roberts JL. Modulation of basal and corticotropin-releasing factor-stimulated proopiomeianocortin gene expression by vasopressin in rat anterior pituitary. Endocrinology 1989; 125: 2957-2966.
62. Ur E, Grossman A. The neuroregulation of corticotropin secretion. In: The pituitary gland, H Imura (ed), New York, Raven Press Ltd 1994, pp: 309-330.
63. Franci CR, Anselmo-Franci JA, Kozlowski JA, McCann SM. Action of endogenous vasopressin and oxytocin on anterior pituitary hormone secretion. Neuroendocrinology 1993; 57: 693-699.
64. Herman JP, Adams D, Prewitt C. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995; 61: 180-190.
65. Whitnall MH, Smyth D, Gainer H. Vasopressin coexists in half of the corticotropin-releasing factor axons present in the extrenal zone of the median eminence in normal rats. Neuroendocrinology 1987; 45: 420-424.
66. Bartanusz V, Aubry J-M, Jezova D, Baffi J, Kiss JZ. Up-regulation of vasopressin mRNA in paraventricular hypophysiotropic neurons after acute immobilization stress. Neuroendocrinology 1993; 58. 625-629.
67. Bartanusz V, Jezova D, Bertini LT, Tilders FJH, Aubry JM, Kiss JZ. Stress-induced increase in vasopressin and corticotropin-releasing factor expression in hypophysiotropic paraventricular neurons. Endocrinology 1993; 132: 895-902.
68. Whitnall MH. Stress selectively activates the vasopressin-containing subset of corticotropin-releasing hormone neurons Neuroendocrinology 1989; 50: 702-707.
69. De Goeij DCE, Binnekade R, Tilders FJH. Chronic stress enhances vasopressin but not corticotropin-releasing factor secretion during hypoglycemia. Am J Physiol 1992; 263: E394-E399.
70. De Goeij DCE, Dijkstra H, Tilders FJH. Chronic psychosocial stress enhances vasopressin but not corticotropin releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 1992; 131: 847-853.
71. Bugajski J, Ga̧dek-Michalska A, Olowska A, Borycz J, Bugajski AJ. Effect of corticotropin-releasing hormone on the pituitary-adrenocortical activity under basal and social stress conditions. J Physiol Pharmacol 1994; 45: 593-601.
72. Bugajski J, Borycz J, Głód R, Bugajski AJ. Crowding stress impairs the pituitary-adrenocortical responsiveness to the vasopressin but not corticotropin releasing hormone stimulation. Brain Res 1995; 681: 223-228.
73. Aguilera G. Regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 1994; 15: 321-350.
74. Morimoto A, Watanade T, Morimoto K, Nakamori T, Murakami N. Possible involvement of prostaglandins in psychological stress induced responses in rats. J Physiol 1991; 443: 421-429.
75. Bugajski J, Olowska A, Ga̧dek-Michalska A, Borycz J, Głód R, Bugajski AJ. Effect of indomethacin on the CRH- and VP-induced pituitary-adrenocortical response during social stress. Life Sci 1996; 58: PL 67-72.
76. Lavicky J, Dunn AJ. Corticotropin releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assesed by microdialysis. J Neurochem 1993; 60: 602-612.
77. Bugajski J, Ga̧dek-Michalska A, Borycz J, Głód R, Bugajski AJ. The corticosterone response to cholinergic and CRH receptor stimulation in rats exposed to social crowding stress. Inflamm Res 1995; 44: Suppl 1, S42-S43.
78. Bugajski J, Ga̧dek-Michalska A, Borycz J. Social crowding stress diminishes the pituitary-adrenocortical and hypothalamic histamine response to adrenergic stimulation. J Physiol Pharmacol 1993; 44: 447-456.